Variability of treatment of locally advanced cervical cancer: How French multidisciplinary teams follow European guidelines?
Jonathan Sabah,Ines Menoux,Lauriane Eberst,Massimo Lodi,Justine Gantzer,Henri Azais,Houssein El Hajj,Vincent Balaya,Guillaume Babin,Sophie Espenel,Yohann Dabi,Manon Kissel,Tran Phuong Lien,Martina Aida Angeles,Francois Margueritte,Elise Deluche,Alexis Marouk,Pierrick Le Borgne,Mah-Soune Apithy,Enora Laas-Faron,Chérif Akladios,Lise Lecointre,For SFOG Campus: Societe Française d’Oncologie Gynécologie,Martina Angeles Fité,Pierrick Le borgne
DOI: https://doi.org/10.1016/j.ejso.2024.108281
IF: 4.037
2024-03-01
European Journal of Surgical Oncology
Abstract:INTRODUCTION: Cervical cancer is a global public health concern. Despite ESGO recommendations and FIGO classification changes, management of locally advanced cervical cancer (LACC) remains debated in France. Our study aimed to review LACC treatment practices and assess adherence to ESGO recommendations among different practitioners.METHODS: From February 2021 to August 2022, we conducted a survey among gynecologic oncology surgeons, radiation oncologists, and medical oncologists practicing in France and managing LACC (FIGO stages IB3-IVA) according to the 2018 FIGO classification. We analyzed responses against the 2018 ESGO recommendations as a "gold standard."RESULTS: Among 115 respondents (56% radiation oncologists, 30% surgeons, 13% medical oncologists), 48.6% of gynecologic surgeons didn't perform para-aortic lymphadenectomy (PAL) with significant radiologic pelvic involvement. PAL, when indicated by PET-CT, was more common in university hospitals (66.7% of surgeons). Surgeons in university hospitals also followed ESGO recommendations more closely. Overall, compliance with all ESGO recommendations was low: 5.7% of surgeons, 21.5% of radiation oncologists, and 60% of medical oncologists. Prophylactic para-aortic irradiation, per ESGO, was more frequent in comprehensive cancer centers (52% of radiation oncologists).CONCLUSION: Adherence to ESGO recommendations for LACC treatment appears low in France, particularly in surgery, with limited PAL in cases of lymph node negativity on PET-CT. However, these recommendations are more often followed by surgeons in university hospitals and radiation oncologists in cancer centers. Adherence to these recommendations may impact patient survival and warrants evaluation of care quality, justifying the organization of LACC management in expert centers.
oncology,surgery